BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lo Sardo F, Canu V, Maugeri-Saccà M, Strano S, Blandino G. YAP and TAZ: Monocorial and bicorial transcriptional co-activators in human cancers. Biochim Biophys Acta Rev Cancer 2022;1877:188756. [PMID: 35777600 DOI: 10.1016/j.bbcan.2022.188756] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Wei L, Ma X, Hou Y, Zhao T, Sun R, Qiu C, Liu Y, Qiu Z, Liu Z, Jiang J. Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma. Cell Death Discov 2023;9:30. [PMID: 36693834 DOI: 10.1038/s41420-023-01319-y] [Reference Citation Analysis]
2 Zhang W, Luo J, Xiao Z, Zang Y, Li X, Zhou Y, Zhou J, Tian Z, Zhu J, Zhao X. USP36 facilitates esophageal squamous carcinoma progression via stabilizing YAP. Cell Death Dis 2022;13:1021. [PMID: 36470870 DOI: 10.1038/s41419-022-05474-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang L, Zhu Z, Liang Q, Tao Y, Jin G, Zhong Y, Dai J, Dai R, Wang Z, Chen J, Zhou L, Ke S, Zheng B, Lan L, Lin X, Chen T. A novel small molecule glycolysis inhibitor WZ35 exerts anti-cancer effect via metabolic reprogramming. J Transl Med 2022;20:530. [DOI: 10.1186/s12967-022-03758-0] [Reference Citation Analysis]